New peptides to target Alzheimer’s culprit

Scientists at Israel’s Bar-Ilan University, working with Canadian scientists have developed peptides (small proteins) that in laboratory tests prevent the production of oligomers – small polymers that are the true culprits of the neuron damage in Alzheimer’s disease.

https://www.israel21c.org/treatment-for-very-early-alzheimers-under-development/

https://www.pnas.org/doi/10.1073/pnas.2210766119

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *